US NewsDrugmaker Declines FDA Request to Pull Treatment After Patient DeathsSarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.SavePrintThe U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch TimesZachary StieberSenior Reporter7/21/2025|Updated: 7/22/20250:00X 1Update: Sarepta is halting all shipments of Elevidys.Original story below.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.Share this articleLeave a commentZachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected ArticlesHow the Child Vaccine Schedule Could Change Under Trump’s DirectiveDec 12, 2025Review Finds Scant Evidence of Benefit for Medical CannabisDec 12, 2025New Chair of CDC Vaccine Panel Fired, Then Rehired by HospitalDec 12, 2025FDA Proposes Allowing Sunscreen Ingredient Used in Other CountriesDec 11, 2025